Trial Profile
Phase II study of docetaxel and capecitabine as 1st line therapy for patients with locally advanced or metastatic gastric cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2007
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 01 Nov 2005 New trial record.